(Q27027854)

language of work or name

1 reference

October 2011

1 reference

1 reference

18

1 reference

issue

4

1 reference

page(s)

216-21

1 reference

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Costs of allogeneic hematopoietic cell transplantation with high-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Costs of pediatric allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

HLA matching in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

High-resolution typing for unrelated donor transplantation: how far do we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

The great debate: haploidentical or cord blood transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Haploidentical transplantation for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800402

10.1177/107327481101800402

21 January 2018

Identifiers

DOI

0 references

PubMed publication ID

21976240

1 reference